Clinical Trials Directory

Trials / Unknown

UnknownNCT03276611

Assessment of Pulmonary Artery Pressure and Right Sided Hemodynamics in Patients With OSA Before and After CPAP TTT

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Accepted

Summary

Obstructive sleep apnea (OSA) is a frequent sleep-related breathing disorder with an incidence of 5-20% in the middle-aged population in Europe and Northern America . plumonary hypertension is present in 12%-34% of patients with osa.continous positive air way pressureis the main standard treatment ofOSA.Echocardiograghy is the most common non invasive imaging method for assessment the effect on right ventricular function.

Detailed description

Obstructive sleep apnea (OSA) is a frequent sleep-related breathing disorder with an incidence of 5-20% in the middle-aged population in Europe and Northern America . Pathophysiologic consequences of OSA are increased sympathetic activity, hypoxia, hypercapnia, increased left ventricular after-load , acute arterial hypertension, increased diastolic and systolic pressure of the right ventricle, atrial dilation. Recent studies have shown that OSA is an independent risk factor for cardiovascular mortality and morbidity. OSA has a social impact because of fragmentation of sleep leads to increased daytime sleepiness, decreased intellect, behavioral and personality changes, enuresis and sexual dysfunction. Pulmonary hypertension is present in 12%-34% of patients with Obstructive Sleep Apnea syndrome. When PH occurs as a consequence of OSA however symptoms may not be present because of obesity and alack of physical exertion or symptoms of PH may be overlapped by other cardiovascular abnormalities. Continuous positive air way pressure therapy is the main standard treatment of OSA works the best in the most people as positive pressure ventilation functions as a pneumatic splint for the collapsing upper air way. Echocardiography is the most common non invasive imaging method for assessment the effect of right ventricular function.

Conditions

Interventions

TypeNameDescription
OTHERechocardiograghytransthoracic echocardiograghy

Timeline

Start date
2017-04-01
Primary completion
2018-03-31
Completion
2018-12-31
First posted
2017-09-08
Last updated
2017-09-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03276611. Inclusion in this directory is not an endorsement.